Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV001848175 | SCV002105652 | likely pathogenic | Hereditary spastic paraplegia | 2020-10-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002034743 | SCV002218715 | pathogenic | Hereditary spastic paraplegia 4 | 2021-06-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser302Leufs*14) in the SPAST gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPAST are known to be pathogenic (PMID: 20932283). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with SPAST-related conditions. For these reasons, this variant has been classified as Pathogenic. |